Literature DB >> 16979903

In vivo inactivation of pRb, p107 and p130 in murine neuroprogenitor cells leads to major CNS developmental defects and high seizure rates.

Julie A McLear1, German Garcia-Fresco, Manzoor A Bhat, Terry A Van Dyke.   

Abstract

Nestin-positive cells were targeted for pRb, p107 and p130 (pRb(f)) inactivation by expression of T(121), a truncated SV40 large T antigen that selectively binds to and inactivates pRb(f). Cre expression was initiated under GFAP control, resulting in T(121) expression restricted to neuroprogenitor cells beginning at embryonic day 11.5 (E11.5). Bi-transgenic embryos showed aberrant central nervous system (CNS) cell proliferation and apoptosis by E13.5. Defects in cortical development were evident with primary effects resulting in depletion of neural progenitors and aberrant cellular migration. Consequently, juvenile and adult brain morphology was reproducibly abnormal, including disorganization of neocortical, hippocampal and cerebellar regions. These aberrations resulted in behavioral phenotypes, including ataxia and seizures. The data indicate that inactivation of pRb(f) in radial glial cells, a population of neuroprogenitor cells, leads to specific disruptions in CNS patterning. The neuroprogenitor-restricted transgene expression provides a model in which to explore both developmental mechanisms and functional neurological outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979903     DOI: 10.1016/j.mcn.2006.07.012

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

Review 1.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 2.  Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases.

Authors:  Stephen Amato; Heng-Ye Man
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 3.  Cell cycle regulation during neurogenesis in the embryonic and adult brain.

Authors:  Arquimedes Cheffer; Attila Tárnok; Henning Ulrich
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

4.  Cyclin-dependent kinase 2-associating protein 1 commits murine embryonic stem cell differentiation through retinoblastoma protein regulation.

Authors:  Yong Kim; Amit Deshpande; Yanshan Dai; Jeffrey J Kim; Anne Lindgren; Anne Conway; Amander T Clark; David T Wong
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

5.  AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development.

Authors:  Biplab Dasgupta; Jeffrey Milbrandt
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

6.  G1 arrest and differentiation can occur independently of Rb family function.

Authors:  Stacey E Wirt; Adam S Adler; Véronique Gebala; James M Weimann; Bethany E Schaffer; Louis A Saddic; Patrick Viatour; Hannes Vogel; Howard Y Chang; Alex Meissner; Julien Sage
Journal:  J Cell Biol       Date:  2010-11-08       Impact factor: 10.539

7.  Intestinal hyperplasia induced by simian virus 40 large tumor antigen requires E2F2.

Authors:  M Teresa Sáenz-Robles; Jennifer A Markovics; Jean-Leon Chong; Rene Opavsky; Robert H Whitehead; Gustavo Leone; James M Pipas
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  Transcriptome profiling of the C. elegans Rb ortholog reveals diverse developmental roles.

Authors:  Natalia V Kirienko; David S Fay
Journal:  Dev Biol       Date:  2007-02-21       Impact factor: 3.582

Review 9.  Cell-context specific role of the E2F/Rb pathway in development and disease.

Authors:  Victoria A Swiss; Patrizia Casaccia
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

10.  Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning.

Authors:  S Hatazaki; C Bellver-Estelles; E M Jimenez-Mateos; R Meller; C Bonner; N Murphy; S Matsushima; W Taki; J H M Prehn; R P Simon; D C Henshall
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.